Tobacco giant Philip Morris International is to move ahead with its controversial acquisition of the UK-based Vectura Group, after obtaining support for roughly three-quarters of the inhaler manufacturer’s shares, a move that renders unconditional its £1.1bn ($1.5bn) cash takeover offer.
Philip Morris Closes In On Vectura As £1.1bn Offer Passes Threshold
Takeover Steeped In Controversy, With Objections Raised By Healthcare Charities
Philip Morris once again pledged to up R&D in Vectura after its £1.1bn takeover offer for the UK-based inhalation specialist became unconditional, following the tobacco giant’s acrimonious face-off with private equity Carlyle earlier this year.
